Balchem (BCPC) EBITDA (2010 - 2026)

Balchem (BCPC) has reported EBITDA for 17 consecutive years, with $59.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBITDA rose 15.12% year-over-year to $59.2 million in Q2 2026; TTM through Jun 2026 was $221.7 million, a 12.04% increase from a year earlier, with the FY2025 full-year figure at $209.3 million, up 14.44% from the prior year.
• EBITDA was $59.2 million for Q2 2026 at Balchem, up from $55.6 million in the prior quarter.
• Over five years, EBITDA peaked at $59.2 million in Q2 2026 and troughed at $33.3 million in Q4 2022.
• A 5-year average of $45.1 million and a median of $44.7 million in 2023 frame the typical range for EBITDA.
• Across the five-year window, EBITDA jumped 30.49% in 2022 and dropped 10.25% in 2023, its largest moves.
• Over 5 years, EBITDA stood at $33.3 million in 2022, then increased by 15.1% to $38.3 million in 2023, then advanced by 23.76% to $47.4 million in 2024, then increased by 10.21% to $52.3 million in 2025, then grew by 13.25% to $59.2 million in 2026.
• The last three EBITDA figures came in at $59.2 million (Q2 2026), $55.6 million (Q1 2026), and $52.3 million (Q4 2025), per Business Quant data.